• Explore /
  • Poster
  • / Pembrolizumab (pembro) for advanced biliary adenocarcinoma: Results from the KEYNOTE-028 (KN028) and KEYNOTE-158 (KN158) basket studies.

Pembrolizumab (pembro) for advanced biliary adenocarcinoma: Results from the KEYNOTE-028 (KN028) and KEYNOTE-158 (KN158) basket studies.

Abstract Poster

Authors

null

Yung-Jue Bang

Seoul National University College of Medicine, Seoul, South Korea

Yung-Jue Bang , Makoto Ueno , David Malka , Hyun Cheol Chung , Adnan Nagrial , Robin Kate Kelley , Sarina Anne Piha-Paul , Willeke Ros , Antoine Italiano , Kazuhiko Nakagawa , Hope S. Rugo , Filippo G. De Braud , Andrea I. Varga , Aaron Richard Hansen , Chao Gao , Suba Krishnan , Kevin Norwood , Toshihiko Doi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT02054806 and NCT02628067

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4079)

DOI

10.1200/JCO.2019.37.15_suppl.4079

Abstract #

4079

Poster Bd #

184

Abstract Disclosures

Similar Posters

First Author: Jae-Lyun Lee

First Author: Wei Li

Poster

2020 Genitourinary Cancers Symposium

ABLE: single-arm trial of nab-paclitaxel with ANTI-PD1 in advanced urothelial cancer.

ABLE: single-arm trial of nab-paclitaxel with ANTI-PD1 in advanced urothelial cancer.

First Author: Jason Brown

First Author: Junho Kang